We found that Her2+ breast cancer cells have increased TrkB protein levels in response to astrocyte-derived BDNF stimulation, resulting in the formation of TrkB and Her2 heterodimers and brain metastases. The gene discussed is NTRK2; the disease is breast carcinoma.